References
- Kern W. Insulin-euglycemia therapy. LS Nelson . Goldfrank's Toxicologic Emergencies. New York: McGraw Hill; 2011: 893–895.
- Greene SL, Gawarammana I, Wood DM, Jones AL, Dargan PI. Relative safety of hyperinsulinemia/euglycemia therapy in the management of calcium channel blocker overdose: a prospective study. Intens Care Med 2007; 33:2019–2024.
- Kerns W, Schroeder D, Williams C, Tomaszewski C, Raymond R. Insulin improves survival in a canine model of acute beta-blocker toxicity. Ann Emerg Med 1997; 29:748–757.
- Vogt S, Mehlig A, Hunziker P, Scholer A, Jung J, Gonzalez AB, Weinmann W, Marsch S. Survival of severe amlodipine intoxication due to medical intensive care. Forens Sci Int 1999; 161:216–220.
- DeRoos FJ. Calcium channel blockers. LS Nelson . Goldfrank's Toxicologic Emergencies. New York: McGraw Hill; 2011: 884–892.
- Holger JS, Engebretsen KM, Marini J. High dose insulin in toxic cardiogenic shock. Clin Toxicol 2009; 47:303–307.
- Stone CK, Thomas SH, Koury SI, Low RB. Glucagon and phenylephrine combinations vs glucagon alone in experimental verapamil overdose. Acad Emerg Med 1996; 3:120–125.
- Holger JS, Engebretsen KM, Fritzlar SJ, Patten LC, Harris CR, Flottemesch TJ. Insulin vs vasopressin and epinephrine to treat b-blocker toxicity. J Toxicol Clin Toxicol 2007; 45:396–401.
- Engebretsen KM, Morgan MW, Stellpflug SS, Cole JB, Anderson CP, Holger JS. Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome. Clin Toxicol 2010; 48:806–812.
- Kerns W, Schroeder D, Williams C, Tomaszewski C, Raymond R. Insulin improves survival in a canine model of acute β-blocker toxicity. Ann Emerg Med 1997; 29:748–757.
- Stellpflug SJ, Harris CR, Engebretsen KM, Cole JB, Holger JS. Intentional overdose with cardiac arrest treated with intravenous fat emulsion and high-dose insulin. Clin Toxicol 2010; 48:227–229.
- Stellpflug SJ, Fritzlar SJ, Cole JB, Engebretsen KM, Holger JS. Cardiotoxic overdose treated with intravenous fat emulsion and high dose insulin in the setting of hypertrophic cardiomyopathy. J Med Toxicol 2010; epub ahead of print.
- Shepherd G, Klein-Schwartz W. High-dose insulin therapy for calcium-channel blocker overdose. Ann Pharmacother 2005; 39: 923–930.
- Greene SL, Gawarammana I, Wood DM, Jones AL, Dargan PI. Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective study. Intens Care Med 2007; 33:2019–2024.
- Megarbane B, Karyo S, Abidi K, Delhotal-Landes B, Aout M, Sauder P, Baud FJ. Predictors of mortality in verapamil overdose: usefulness of serum verapamil concentrations. Basic Clin Pharmacol Toxicol. Accepted article; doi: 10.1111/j.1742-7843.2010.0066.x.
- Kline JA, Leonova E, Raymond RM. Beneficial myocardial effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med 1995; 23:1251–1263.
- Clerk LH, Vincent MA, Lindner JR, Clark MG, Rattigan S, Barrett E. The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake. Diabetes Metab Res Rev 2004; 20:3–12.
- De Backer D, Creteur J, Dubois MJ, Sakr Y, Vincent JL. Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J 2004; 147:91–99.
- Balbis A, Baquiran G, Bergeron JJM. Compartmentalization and insulin-induced translocations of insulin receptor substrates, phosphatidylinositol 3-kinase, and protein kinase B in rat liver. Endocrinology 2000; 141:4041–4049.
- von Lewinski D, Bruns S, Walther S, Kogler H, Pieske B. Insulin causes [Ca2 + ]i-dependent and[Ca2 + ]i-independent positive inotropic effects in failing human myocardium. Circulation 2005; 111:2588–2595.
- Hsu CH, Wei J, Chen YC, Yang SP, Tsai CS, Lin CI. Cellular mechanisms responsible for the inotropic action of insulin on failing human myocardium. J Heart Lung Transplant 2006; 25:1126–1134.